Summary
Successful exploitation of this vulnerability could allow the Active Directory (AD) credentials of a previously authenticated user to gain access to the device. This could result in an attacker having the same level of privilege previously granted to a user prior to account expiration, and could allow access to patient data and medications. For exploitation to occur, products must be actively using AD for login and be connected to the hospital domain. Users who do not use AD are not impacted by this vulnerability.
Vulnerabilities 1
-
Unscored —
In Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12,…
Revision history
-
#2
ICSMA-19-248-01 BD Pyxis (Update A)
-
#1
ICSMA-19-248-01 BD Pyxis
References
-
ICS Advisory ICSMA-19-248-01 Web Version
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-19-248-01
-
Recommended Practices
https://www.us-cert.gov/ncas/tips/ST04-014
-
Recommended Practices
https://www.us-cert.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
-
Recommended Practices
https://www.us-cert.gov/ics/tips/ICS-TIP-12-146-01B